View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
MCL Younger Trial, R-DHAP - Rituximab 375 / Cisplatin 100 / Cytarabine 2000 / Dexamethasone 40, Mantle Cell Lymphoma Cycle 2, 4, 6
Protocol-ID: 325 V1.1 (Mini), MCL Younger Trial, R-DHAP (RITU375/CISP100/CYTA2000/DEXA40), MCL C2,4,6Indication(s)
- Mantle Cell Lymphoma; ICD-10 C83.1
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 10.01.2023